Skip to main content
. Author manuscript; available in PMC: 2008 Dec 20.
Published in final edited form as: Virology. 2007 Oct 24;369(2):400–410. doi: 10.1016/j.virol.2007.08.032

Figure 5. TRIM5αrh potency against FIV maps to the v1 region of the B30.2 domain.

Figure 5

Figure 5

CRFK cells expressing the indicated wild-type and TRIM5αrh-TRIM5αhu chimeric proteins (A) were Western blotted with an antibody directed against the HA epitope tag and control anti-β-actin antibody (B). Cells were challenged with FIV-GFP (C). GFP-positive cells were counted. Similar results were obtained in three independent experiments.